Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 535 | 571 | 507 |
| Operating Income | -535 | -571 | -507 |
| Interest Expense | 19 | 18 | 22 |
| Other Income | 2 | 1 | -6 |
| Pre-tax Income | -552 | -588 | -536 |
| Net Income Continuous | -552 | -588 | -536 |
| Net Income | $-552 | $-588 | $-536 |
| EPS Basic Total Ops | -0.02 | -0.03 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.02 |
| EBITDA(a) | $-510 | $-548 | $-498 |